These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3874729)

  • 1. Reduced complement-mediated immune complex solubilization in leprosy patients.
    Ramanathan VD; Sharma P; Ramu G; Sengupta U
    Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
    Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions.
    Ramanathan VD; Tyagi P; Ramanathan U; Katoch K; Sengupta U; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):5-11. PubMed ID: 2030316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions.
    Ramanathan VD; Thyagi P; Ramanathan U; Katoch K; Ramu G
    Indian J Lepr; 1998; 70(2):153-60. PubMed ID: 9724850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
    Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.
    Schifferli JA; Steiger G; Hauptmann G; Spaeth PJ; Sjöholm AG
    J Clin Invest; 1985 Dec; 76(6):2127-33. PubMed ID: 2934406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
    Kerr MA; Wilton E; Naama JK; Whaley K
    Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
    Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
    Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional state of the complement system in leprosy.
    Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
    Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of IgA immune precipitates by complement.
    Miller GW
    J Immunol; 1976 Oct; 117(4):1374-7. PubMed ID: 977953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
    Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
    Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA; Morris SM; Dash A; Peters DK
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.